Article
Tom Caravela
From MSL to MSL Recruiter: A Career Transition
Summary
In this episode, Sarah Snyder shares her journey from BioSplice to becoming an MSL recruiter at The Carolan Group. She emphasizes the value of networking and building a strong LinkedIn presence, discussing the emotional challenges of career transitions. Sarah highlights the parallels between MSL and recruiter roles, offering insights into fostering effective recruiter-candidate relationships through transparency and engagement. She provides networking strategies while cautioning against burnout. As the episode celebrates its 100th milestone, Sarah offers reflections and advice for MSL job seekers, encouraging them to maintain updated profiles and embrace career transitions.
My guest today is Sarah Snyder, Executive MSL Recruiter with The Carolan Group and we discuss her career transition from Medical Science Liaison to MSL Recruiter
Sarah shares…
👉 How she made the unique career transition
👉 Why it is a good idea for a job seekers to work with a Recruiter
👉 What is the best way for a job seeker to engage a Recruiter
👉 What Job Seekers do to ensure a successful relationship with a Recruiter
Sarah Snyder, MSL recruiter, networking strategies, career transitions, recruiter-candidate relationships
Related Topics
You May Also Like
Tom Caravela
Podcast
MSL Talk: Tom Caravela, Sarah Snyder
Surround to Succeed: Building a Motivational Network
Podcast
MSL Talk: Tom Caravela, George Lehman
Job Leads: The Do's and Don't of Asking for Referrals
Article
Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
Article
Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
Article
Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS